Covidien has announced that Bryan Hanson, who currently serves as group president, Medical Devices & US, will be elevated to the newly created position of group president, Covidien, effective 1 October. In this role, Hanson will have global responsibility for all Covidien business segments.
Hanson has overseen the company’s Surgical Solutions, Vascular Therapies and Respiratory & Monitoring Solutions business units, as well as its Health Systems organisation, since October 2013. He recently assumed oversight of the company’s Emerging Markets business and will add responsibility for the company’s Developed Markets and Medical Supplies businesses when his appointment becomes effective.
“Bryan is a proven global leader who has deep experience in our industry and will help advance our company in delivering new value, products and capabilities to our customers and patients around the world,” says José E Almeida, chairman, president and chief executive officer, Covidien. “This new organisational structure addresses important business requirements while positioning Covidien for the future.”
Hanson joined Covidien in 1992 and has held positions of increasing responsibility in sales, marketing and general management. Prior to being appointed group president, Medical Devices & US, Hanson served as group president, Surgical Solutions, and president, Energy-based Devices. Hanson holds a Bachelor of Science degree in Finance from Florida State University.